skip to content

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.